top of page
NHSÂ Consultation on Investing in Specialised Services
On 23rd April 2015, Cancer52 responded to the NHS public consultation on Investing in Specialised Services. In summary Cancer52 believes...
Consultation on Investing in Specialised Services
On 23 April, Cancer52 responded to the NHS public consultation on Investing in Specialised Services. Read more of our submission.
Cancer52 All Members Meeting - Tuesday 21st April 2015
We are pleased to share the presentations delivered at the quarterly All Members Meeting on 21st April 2015 at Wellington House: Nicky...
Cancer52 All Members Meeting - 21st April 2015
We are pleased to share the presentations delivered at the quarterly All Members Meeting on 21st April 2015 at Wellington House: Dr...


Jonathan Pearce appointed as Chair of Cancer52
Cancer52 is delighted to announce that Jonathan Pearce, chief executive of the Lymphoma Association, has been appointed as Chair of...
Cancer52 Patient Engagement Event - Tuesday 3rd March 2015
We are pleased to share with members the presentations given at the Cancer52 Patient Engagement Event at Friends House: Daniel Ratchford...
Cancer Taskforce Strategy workshop - Wednesday 18 February 2015
Some 15 Cancer52 members attended the Cancer Strategy workshop. The attendees spent two hours providing feedback in three areas:...
All Members Meeting - Tuesday 27 January 2015
We are pleased to share with members the presentations given at the meeting at the House of Lords: NCIN Presentation by Sam Johnson,...
Cancer52 Chair joins NHS England Cancer Taskforce
www.england.nhs.uk/2015/01/11/beat-cancer On Sunday 11th January 2015 NHS England announced details of a new independent taskforce being...
Cancer52 Statement re Cancer Drug Fund (CDF) Delistings
As a member of the Cancer Drug Fund (CDF) Charity Group Cancer52 has signed an open letter to Professor Peter Clark, Chair of the CDF....
bottom of page